Supplementary Materials and Methods Sphere formation assay. Cellswere resuspended in serum-free medium DMEM-F12 (Invitrogen, Carlsbad, California), supplemented with 4μg/ml insulin (Sigma, St Louis, MO), 20ng/ml epidermal growth factor (Peprotech, Rocky Hill, NJ), 20 ng/ml basic FGF (Peprotech, Rocky Hill, NJ), B27 (1:50 Invitrogen, Carlsbad, California) and 0.4 % BSA. Cells were plated onto ultralow attachment plates (Corning, New York, USA). Every three days, 200l 0.8% BSA F12 medium containing EGF, insulin was added. 14 days after seeding, the number of spheroids was measured under a microscope. For serial passage of spheres, the spheres were collected by centrifugation, dissociated into single cell with trypsin and cultured under conditions described above. Flow cytometry analysis. For cell surface marker analysis, cultured cells were trypsinized, washed, and resuspended in PBS supplemented with 2% fetal bovine serum. Cells were then incubated with anti-EpCAM antibody (Calbiochem, La Jolla, CA), PE anti-CD133 (MiltenyiBiotec, Auburn, CA), FITC anti-CD90 (Biolegend, San Diego, CA),PE anti-CD44(eBioscience, San Diego, CA)and PE anti-CD13(Biolegend, San Diego, CA)to detect EpCAM, CD133, CD90, CD44 or CD13 and analyzedwith the BD FACS Aria cell sorting system (BD Biosciences, Bedford, MA). For side population (SP) analysis of cells, cells were detached from the dishes with 0.25% trypsin, washed twice with PBS, resuspended in DMEM medium supplemented with 10% fetal bovine serum at a concentration of 1×106 cells/ml and culture incubated at 37℃ in a 5% CO2 incubator for 10 min. Cells were incubated at 37°C for 90 minutes with 20 μg/mL Hoechst 33342 (Sigma, St Louis, MO), either alone or in presence of 50μmol/L Verapamil (Sigma, St Louis, MO).Cells were washed, centrifuged and resuspended in ice-cold PBS. Then, 1μg/mL propidium iodide (Sigma, St Louis, MO) was added and filtered through a 40μm cell strainer (BD Falcon) to obtain single suspension cells. Cell viability and chemo-resistance assay.Cells infected with LV-shTip30 and LV-shNon were detached, counted and seeded into 96-well plates at 5000 cells per well. 24 hours later, fluorouracil, pharmorubicin or cisplatin was obtained from Changhai-Hospital and added into the medium with their corresponding IC 50 (7500M, 1.72M, and 13.33M). Medium was removed and washed with PBS twice after the designed time point, respectively (24h, 48h, 72h, and 96h). Cell viability was determined by MTS assay reagent (CellTiter 96 AQueous one Solution Cell proliferation Assay; PromegaCorperation, USA) according to manufacturer’s protocol. In addition, various concentrations of the three chemotherapy agents were added, and after 72 hours cell viability was determined in the same way. RNA extraction and reverse transcription PCR.Total RNA was isolated by NucleoSpin RNA II kit (Macherey&Nage, Easton, PA; includes DNase I treatment). First-strand cDNA was generated using the PrimeScript RT reagent Kit (Takara Bio, Tokyo, Japan). Analysis of mRNA levels was performed on a 7500 Fast Real-Time PCR System (Applied Biosystems, Carlsbad, California) with SYBR Green-based real-time PCR. Actin was used as an endogenous control to normalize the amount of total RNA in each sample. The primer sequences are provided as follows (F, forward; R, reverse): Gene symbol TIP30 Bim1 Actin E-cad Nanog Oct4 Slug F Snail1F Sox2 ABCG2 ABCC1 ABCB1 SIP Twist Zeb1 Foxc2 Primer Sequence (5'-3') F:TCACCTTCGACGAGGAAGCT R: GCTCTGCAGACTTCAGACCA F: TGGAGAAGGAATGGTCCACTTC R: GTGAGGAAACTGTGGATGAGGA F: CGTGGACATCCGTAAAGACC R: ACATCTGCTGGAAGGTGGAC F: TGCCCAGAAAATGAAAAAGG R: GTGTATGTGGCAATGCGTTC F: GATTTGTGGGCCTGAAGAAA R: TTGGGACTGGTGGAAGAATC F: CTTGCTGCAGAAGTGGGTGGAGGAA R: CTGCAGTGTGGGTTTCGGGCA F: GGGGAGAAGCCTTTTTCTTG R: TCCTCATGTTTGTGCAGGAG F: AATCGGAAGCCTAACTACAGCG R: GTCCCAGATGAGCATTGGCA F:GCGAACCATCTCTGTGGTCT R:GGAAAGTTGGGATCGAACAA F:CAGGTGGAGGCAAATCTTCGT R:ACCCTGTTAATCCGTTCGTTTT F:CTCTATCTCTCCCGACATGACC R:AGCAGACGATCCACAGCAAAA F:TTGCTGCTTACATTCAGGTTTCA R:AGCCTATCTCCTGTCGCATTA F:CAAGAGGCGCAAACAAGCC R:GGTTGGCAATACCGTCATCC F:GTCCGCAGTCTTACGAGGAG R:GCTTGAGGGTCTGAATCTTGCT F:CTACAACAACAAGACACTGCTGT R:TGTTCTTTCAGAGAGGTAAAGCG F:CCTCCTGGTATCTCAACCACA R:GAGGGTCGAGTTCTCAATCCC Immunoprecipitation.Cell extracts were prepared by sonicating in 25 mmol/L TrisCl (pH7.4), 100 mmol/L NaCl, 0.15% NP40, 0.25 mmol/L EDTA, and 10% glycerol, supplemented with protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO). After centrifugation at 14,000 rpm for 20 min, either rabbit polyclonal anti-His antibody (Cell Signaling Technology, Danvers, MA), anti-TIP30 antibody (generated in our lab1), or IgG1 (1.5 mg antibody/mg extract, Santa Cruz Biotechnology, Santa Cruz, CA) and protein A-agarose (Invitrogen, Carlsbad, California) were added to the supernatant cytoplasmic lysates and incubated at 4 ℃ overnight. The beads were washed three times in the same lysis buffer. Theproteins remaining on beads were analyzed by immunoblotting with relevant antibodies. Microarray analysis.Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, California) and purified with an RNeasy kit (Qiagen, Hilden, Germany). Microarray analysis was performed using the NimbleGen Gene Expression Microarray, with the assistance of the Kangchen biotechnology company. Scanning was performed with the Axon GenePix 4000B microarray scanner. Raw data were extracted as pair files by NimbleScan software (version 2.5). Heat map of relative enrichment scores were derived by gene set enrichment analysis. Core enrichment genes that contributed most to the enrichment result in gene set of 71 EMT-related and stemness-related genes were hierarchical clustered using Cluster 3.0 software. Immunofluorescence staining. Cells were seeded in 24-well plates fixed with 4% paraformaldehyde for 20-30 minutes at room temperature ,then washed with 1×PBS three times and blocked with blocking solution (0.5% Triton X-100/1% BSA/ 1×PBS ) for 1 hour at room temperature. For immunofluorescence staining, cells were incubated with primary antibodies: Snail (1:200, Abcam, Cambridge, MA), E-cadherin (1:50, Cell Signaling Technology, Danvers, MA) and Vimentin (1:100, Cell Signaling Technology, Danvers, MA) at 4℃ overnight on shaker. The next day, after being washed three times, cells were incubated with goat anti-mouse IgG (1:500,Invitrogen, Carlsbad, California) or goat anti-rabbit IgG (1:500, Invitrogen, Carlsbad, California) for 1 hour, and then stained with DAPI (Invitrogen, Carlsbad, California). All matched samples were photographed (control and test) using immunofluorescence microscope. Wound-healing, cell Invasion and migration assay.For wound-healing assay, the cells were first seeded in 6-well culture plates. A wound was made in the confluent monolayer with a plastic pipette tip and the migration of the cells at the wound front was photographed using an inverted microscope at indicated times after the scratch. Ability of cell invasion and migration was evaluated by the Cell Invasion Assay Kit(Millipore) and Transwell® Permeable Support (Corning) according to themanufacturer’s directory. Five microscopic fields were randomly selected tocalculate the total count of the invaded or migrated cells. The relative number of cellshaving penetrated the ECM or basement membrane was used to denote the invasion ormigration ability of the cells. All assays were carried out three times.Two independent investigators were blinded when reading the migration and invasion assays. 5-Aza-2’-deoxycytidine (5-Aza-2_dC) treatment. HCC cells were seeded in 6-well plate and cultured in medium supplemented with 5-Aza-2_dC (Sigma-Aldrich, St. Louis, MO) at the indicated concentrations for 4 days and then subjected to RNA extraction. Chemicals and reagents Proteasome inhibitors MG132 was purchased from Sigma and used at final concentrations of 30uM. Cycloheximide was purchased from Sigma and used at final concentrations of 50ug/ml. MK-2206 was obtained from Selleck Chemicals and used at final concentrations of 0.5 uM. 1 Tong X, Li K, Luo Z, Lu B, Liu X, Wang T et al. Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol 2009; 174: 1931-1939.